Contact this trialFirst, we need to learn more about you.
Chemotherapy
SNDX-5613 + Chemotherapy for Leukemia
Recruiting1 awardPhase 1
San Francisco, California
This trial is testing a new drug called revumenib combined with chemotherapy in patients whose leukemia has returned or did not respond to previous treatments and have specific genetic changes. The drug aims to block these genetic changes to make the chemotherapy more effective.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service